Forvard P/S multiplikatori: American Oncology Network Inc (AONC)

American Oncology Network, Inc. - AONC emitenti grafik logotipi

Bemorlarning doimiy oqimi American Oncology Network (AONC) tarmog'ini rivojlantirish uchun kapitalning ritmik aylanmasini ta'minlaydi. Prognozlarga asoslangan forward P/S baholash tendentsiyasini vizuallashtiradi, bunda 0.00 metriki ushbu darajani belgilaydi. Biroq, sog'liqni saqlash gigantlari tomonidan bozor konsolidatsiyasi mustaqil o'sishni cheklaydi. Eksklyuziv sug'urta shartnomalari va FDA ning qat'iy nazorati kirish uchun yuqori to'siqlarni yaratadi.

AONC American Oncology Network, Inc.: Sotuvga nisbatan forvard narx 30.03.2024 - 04.08.2024 oraligʻida

American Oncology Network, Inc. (AONC) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning fundamental tahlili:AONC (American Oncology Network Inc)
aoncology.com tovar namunasi

Fundamental jihatdan barqaror aktivlarni aniqlash bozor qiymatining kutilayotgan savdo hajmi nisbatini tahlil qilishni talab etadi. Biznesning forward P/S ko'rsatkichi o'sish premiumini o'lchash uchun joriy kapitalizatsiyani daromad kutsivlari bilan birlashtiradi; American Oncology Network (AONC) uchun ushbu dinamika klinikalarning ularning integratsiyalashgan AI platformasi va dorixona tarmog'iga bog'liqligini monetizatsiya qilishga bo'lgan bozor ishonchini aks ettiradi, bu esa ushbu grafikdagi narx harakatini baholashning haddan tashqari qiziganligining muhim ko'rsatkichi qiladi.

American Oncology Network raqobatchilari tahlili

Forvard P/S multiplikatori ONC (BeiGene Oncology)|Forvard P/S multiplikatori Halozyme Corp HALO|RVMD: Forvard narx/daromad multiplikatori|Ascentage Pharma Group (AAPG) - Forvard narx/daromad multiplikatori|CG Oncology Therapeutics (CGON) - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati UroGen Pharma URGN|Narxning prognoz qilingan daromadga nisbati Bicara Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Personalis Genomics PSNL|Forvard P/S multiplikatori ERAS|Narxning kutilayotgan daromadga nisbati DCTH|Y-mAbs Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aura Biosciences Inc (AURA)|CADL: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ARAY (Accuray Inc.)|SLS: Forvard P/S multiplikatori|ACTU: Narxning kutilayotgan daromadga nisbati|CTOR (Citius Oncology Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati tuhurabio.com HURA|Forvard P/S multiplikatori TARA|FATE: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori WHWK (Aadi Bioscience)|TCRX (TScan) - Kelajakdagi narxning daromadga nisbati|Champions Oncology, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati XBiotech Inc XBIT|CVM: Forvard P/S multiplikatori|OSTX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Radiopharm Theranostics Limited|Forvard P/S multiplikatori artivabio.com|Forvard narx/daromad multiplikatori ANL (Adlai Nortye Limited)|Veru - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Tempest Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati xiliotx.com (XLO)|Renovaro - Forvard P/S multiplikatori|Mural Oncology (MURA) - Forvard narx/daromad multiplikatori|KAPA: Forvard P/S multiplikatori|OKUR - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CytoMed Therapeutics Limited|CRIS: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori APLM|Forvard P/S multiplikatori tharimmune.com (THAR)|Advanced Biomed Corp - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx GNPX|Calidi Biotherapeutics, Inc. - Forvard P/S multiplikatori|Sunshine Biopharma (SBFM) - Forvard narx/daromad multiplikatori|XBIO: Forvard P/S multiplikatori|SLRX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PPBT|Forvard P/S multiplikatori BeiGene Ltd.|Narxning prognoz qilingan daromadga nisbati Checkpoint Therapeutics, Inc. (CKPT)|Forvard narx/daromad multiplikatori Elevation Oncology, Inc. ELEV|Forvard P/S multiplikatori ICAD (iCAD Inc.)|IKNA - Forvard narx/daromad multiplikatori|NTBL: Forvard narx/daromad multiplikatori|viracta.com (VIRX) - Forvard narx/daromad multiplikatori|MorphoSys (MOR) - Narxning prognoz qilingan daromadga nisbati|NAYA Biosciences Corp (NAYA) - Forvard P/S multiplikatori|AAPGV (Ascentage) - Forvard P/S multiplikatori